63 related articles for article (PubMed ID: 20832227)
1. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.
Lee SA; Lee CH; Jung WY; Lee J; Choi JW; Kim KA; Park CM
Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227
[TBL] [Abstract][Full Text] [Related]
2. Multifocal hepatic small vessel neoplasm: Imaging features at Gd-EOB-DTPA-enhanced MRI.
Simon G; Lebail B; Calame P
Diagn Interv Imaging; 2023 Nov; 104(11):562-563. PubMed ID: 37758601
[No Abstract] [Full Text] [Related]
3. Lipophilic Group-Modified Manganese(II)-Based Contrast Agents for Vascular and Hepatobiliary Magnetic Resonance Imaging.
Cai Z; Jiang L; Cao Y; Fu S; Wang S; Jiang Y; Gu H; Li N; Fu X; Tang S; Zhu J; Cao W; Zhong L; Cheng Z; Xia C; Lui S; Song B; Gong Q; Ai H
J Med Chem; 2024 Mar; 67(6):5011-5031. PubMed ID: 38450627
[TBL] [Abstract][Full Text] [Related]
4. Pushing the limit of hepatocellular carcinoma diagnosis: diagnosis of subcentimetre HCC using gadoxetic acid-enhanced MRI and alpha-fetoprotein.
Hwang SH; Rhee H
Eur Radiol; 2024 Apr; 34(4):2269-2270. PubMed ID: 37870626
[No Abstract] [Full Text] [Related]
5. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW
AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
[TBL] [Abstract][Full Text] [Related]
6. [Recent Updates of Abbreviated MRI for Hepatocellular Carcinoma Screening].
Kim JW; Lee CH
Taehan Yongsang Uihakhoe Chi; 2021 Mar; 82(2):280-297. PubMed ID: 36238735
[TBL] [Abstract][Full Text] [Related]
7. Expression of Organic Anion Transporting Polypeptides in an H-Ras 12V Transgenic Mouse Model of Spontaneous Hepatocellular Carcinoma.
Kim H; Choi J; Yu DY; Choi HJ
Yonsei Med J; 2021 Jul; 62(7):622-630. PubMed ID: 34164960
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma.
Wang F; Numata K; Okada M; Chuma M; Nihonmatsu H; Moriya S; Nozaki A; Ogushi K; Luo W; Ruan L; Nakano M; Otani M; Inayama Y; Maeda S
Quant Imaging Med Surg; 2021 Jun; 11(6):2521-2540. PubMed ID: 34079721
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary phase hypointensity on gadobenate dimeglumine-enhanced magnetic resonance imaging may improve the diagnosis of hepatocellular carcinoma.
Li Y; Chen J; Weng S; Yan C; Ye R; Zhu Y; Wen L; Cao D; Hong J
Ann Transl Med; 2021 Jan; 9(1):55. PubMed ID: 33553348
[TBL] [Abstract][Full Text] [Related]
10. Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma.
Li XQ; Wang X; Zhao DW; Sun J; Liu JJ; Lin DD; Yang G; Liu H; Xia ZY; Jia CY; Li HJ
World J Surg Oncol; 2020 Aug; 18(1):219. PubMed ID: 32828123
[TBL] [Abstract][Full Text] [Related]
11. Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma.
Kovac JD; Milovanovic T; Dugalic V; Dumic I
World J Gastroenterol; 2020 May; 26(17):2012-2029. PubMed ID: 32536771
[TBL] [Abstract][Full Text] [Related]
12. Benign focal liver lesions masquerading as primary liver cancers on MRI.
Subramanian M; Low HM; Kim MJ; Tan CH
Diagn Interv Radiol; 2020 May; 26(3):168-175. PubMed ID: 32229432
[TBL] [Abstract][Full Text] [Related]
13. Gadoxetic acid-enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background.
Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Koda W; Inoue D; Ogi T; Yoshida K; Gabata T
Eur Radiol; 2020 Jun; 30(6):3438-3447. PubMed ID: 32064560
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma grading and recurrence prediction using T
Qin X; Yang T; Huang Z; Long L; Zhou Z; Li W; Gao Y; Wang M; Zhang X
Oncol Lett; 2019 Sep; 18(3):2322-2329. PubMed ID: 31404322
[TBL] [Abstract][Full Text] [Related]
15. Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update.
Granata V; Fusco R; Avallone A; Catalano O; Filice F; Leongito M; Palaia R; Izzo F; Petrillo A
Infect Agent Cancer; 2017; 12():23. PubMed ID: 28465718
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents?
Park YS; Lee CH; Kim JW; Shin S; Park CM
World J Gastroenterol; 2016 Jan; 22(1):284-99. PubMed ID: 26755877
[TBL] [Abstract][Full Text] [Related]
17. Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.
Hennedige T; Venkatesh SK
World J Gastroenterol; 2016 Jan; 22(1):205-20. PubMed ID: 26755871
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Tumor Ablation for Hepatocellular Carcinoma.
Kang TW; Rhim H
Liver Cancer; 2015 Sep; 4(3):176-87. PubMed ID: 26674766
[TBL] [Abstract][Full Text] [Related]
19. Hepatic angiomyolipoma with special attention to radiologic imaging.
Kuramoto K; Beppu T; Namimoto T; Hayashi H; Imai K; Nitta H; Hashimoto D; Chikamoto A; Ishiko T; Iyama K; Ikeda O; Yamashita Y; Baba H
Surg Case Rep; 2015; 1(1):38. PubMed ID: 26366342
[TBL] [Abstract][Full Text] [Related]
20. Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.
Haimerl M; Wächtler M; Zeman F; Verloh N; Platzek I; Schreyer AG; Stroszczynski C; Wiggermann P
PLoS One; 2014; 9(6):e100315. PubMed ID: 24950259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
